CORRECTION
Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, Mercedes Robles-Diaz, Pablo Saenz-López, Hacibe Hallal, German Soriano, Eva Roman, M. Carmen Fernandez, M. Isabel Lucena, Raúl J. Andrade
There are errors in the Funding section. The correct funding information is as follows: This study was supported, in part, by research grants from the Agencia Española del Medicamento and Fondo de Investigación Sanitaria (PI12/00378). Fondo Europeo de Desarrollo Regional (FEDER). CIBERehd and Red Genómica del Cáncer are funded by Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Reference 1.
Ulzurrun E, Stephens C, Ruiz-Cabello F, Robles-Diaz M, Saenz-López P, Hallal H, et al. (2014) Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort. PLoS ONE 9(4): e94675. doi: 10.1371/journal.pone.0094675 PMID: 24732756
a11111
OPEN ACCESS Citation: Ulzurrun E, Stephens C, Ruiz-Cabello F, Robles-Diaz M, Saenz-López P, Hallal H, et al. (2015) Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of DrugInduced Hepatotoxicity in a Spanish Cohort. PLoS ONE 10(10): e0141400. doi:10.1371/journal. pone.0141400 Published: October 16, 2015 Copyright: © 2015 Ulzurrun et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLOS ONE | DOI:10.1371/journal.pone.0141400 October 16, 2015
1/1
Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort Eugenia Ulzurrun, Camilla Stephens, Francisco Ruiz-Cabello, Mercedes Robles-Diaz, Pablo Saenz-López, Hacibe Hallal, German Soriano, Eva Roman, M. Carmen Fernandez, M. Isabel Lucena, Raúl J. Andrade
There are errors in the Funding section. The correct funding information is as follows: This study was supported, in part, by research grants from the Agencia Española del Medicamento and Fondo de Investigación Sanitaria (PI12/00378). Fondo Europeo de Desarrollo Regional (FEDER). CIBERehd and Red Genómica del Cáncer are funded by Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Reference 1.
Ulzurrun E, Stephens C, Ruiz-Cabello F, Robles-Diaz M, Saenz-López P, Hallal H, et al. (2014) Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of Drug-Induced Hepatotoxicity in a Spanish Cohort. PLoS ONE 9(4): e94675. doi: 10.1371/journal.pone.0094675 PMID: 24732756
a11111
OPEN ACCESS Citation: Ulzurrun E, Stephens C, Ruiz-Cabello F, Robles-Diaz M, Saenz-López P, Hallal H, et al. (2015) Correction: Selected ABCB1, ABCB4 and ABCC2 Polymorphisms Do Not Enhance the Risk of DrugInduced Hepatotoxicity in a Spanish Cohort. PLoS ONE 10(10): e0141400. doi:10.1371/journal. pone.0141400 Published: October 16, 2015 Copyright: © 2015 Ulzurrun et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLOS ONE | DOI:10.1371/journal.pone.0141400 October 16, 2015
1/1
